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To establish an effective approach for inducing expression of the RecQ core of Bloom’s Syndrome 
protein (BLM
642-1290
) and assaying its biological activity in vitro, BLM
642-1290
 recombinant protein was 
expressed with IPTG at room temperature in Escherichia coli, and then the expressed product was 
assayed using SDS-PAGE and western blotting. After purification via affinity chromatography, DNA 
binding activity and unwinding activity of the protein were assessed by fluorescence polarization. 
Furthermore, the ATPase activity of the protein was also assayed using ultraviolet spectrophotometry 
based on PiColorLock Gold reagent. An effective expression method was established for BLM protein in 
E. coli. The obvious bioactivities of the protein were observed in binding to ssDNA or dsDNA, unwinding 
the dsDNA in the presence of ATP, as well as catalyzing ATP hydrolysis in the presence of ssDNA in 
vitro. The prokaryocyte expression method of BLM
642-1290
 was established successfully and the protein 
with biological activity was obtained from recombinant E.coli. This would be significant to provide a 










Bloom’s Syndrome (BS) is a rare, autosomal recessive 
genetic disorder (German et al., 1994). BS patients 
display similar biological properties such as clinical mani-
festations, pre- and postnatal growth retardation, sun-
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infertility in males, immunodeficiency, and a predispo-
sition to most types of cancers (German, 1993; Chisholm 
et al., 2001; Hanada, 2007). This disease is caused by 
mutation of the Bloom’s Syndrome gene (BLM) and the 
gene is located on chromosome 15q26.1 (Mathew et al., 
1993). Cells from BS patients show many cytogenetic 
abnormalities including translocation, chromosome 
breakage, telomeric association and increased rates of 
sister-chromatid exchange (SCEs), which can be used as 
a molecular diagnostic for the disease (Chaganti et al., 
1974; Bryant et al., 1979; German et al., 1974; Furuichi, 
2001).  
The BLM gene encodes a protein called Bloom 
Syndrome protein (BLM) comprising 1417 amino acid, 
which is a member of the RecQ family helicase and plays 
an important role in the maintenance of genomic stability 
(German, 1993; German et al., 1994; Hickson et al., 
2001). The RecQ helicase family is an important member 
of DNA helicases including the BLM, WRN, RECQ1, 





Schizosaccharomyces pombe Rqh1p proteins. Among 
which the BLM, WRN, and RECQ4 are defective in 
Bloom’s, Werner’s and Rothmund-Thomson Syndromes 
in humans (Karow et al., 2000; Furuichi, 2001). Mutations 
in human RecQ genes induced genomic instability and 
cancer (Novotny et al., 2003; Sharma et al., 2005; Mounira, 
2006; Rigu et al., 2008). As most RecQ helicases, BLM 
helicase shows DNA-dependent ATPase activity and 
ATP-dependent 3’ - 5’ DNA helicase activity (Karow et 
al., 1997; Bachrati and Hickson, 2006), BLM can unwinds 
a variety of DNA structures including the holliday junction, 
the triple helix, the D-loop and the highly stable G-
quadruplex structure (Lohman and Bjornson, 1996; 
Karow et al., 1997; Wu et al., 2001; Dutertre et al., 2002). 
The eukaryotic ssDNA binding protein, replication protein 
A, stimulates the unwinding activity of BLM helicase, 
which was necessary for unwinding reinitiation (Brosh et 
al., 2000; Yodh et al., 2009). BLM helicase can interact 
with Topo IIIa (topoiso-merase IIIa) and stimulate its 
helicase activity (Wu and Hickson, 2002). Recent research 
showed that telomerase-associated protein 1 (TEP1), 
heat shock protein 90 (HSP90) and topoisomerase Iiα 
(TOPOIIα) associate with BLM helicase and modulate its 
helicase activity using telomeric DNA substrates in 
immortalized cells (Bhattacharyya et al., 2009). Although 
there have been many intensive studies for BLM protein, 
the pathologic mechanism of Bloom’s Syndrome is still 
poorly under-stood (Sharma et al., 2005; Rigu et al., 
2008). Elucidation of the molecule mechanism of the 
BLM protein may provide the opportunity to develop 
effective anti-cancer strategies (Yang et al., 2010). 
The RecQ core of BLM is consisted of the DEAH, 
RecQ Conserved-Terminal (RecQ-Ct) region, helicase 
and RNAseD C-terminal (HRDC) domains (Janscak et 
al., 2003). DEAH helicase domain is consist of seven 
amino acid sequence motifs that are responsible for 
coupling of ATP hydrolysis to DNA binding, translocation 
and unwinding (Dillingham et al., 2001). The HRDC 
domain is distal to the C-terminus and it is important to 
modulate the helicase function via auxiliary contacts to 
DNA (Liu et al., 1999). The RecQ-Ct domain is unique to 
the RecQ family of helicases and located just after the 
conserved seven signature motifs. To date, the investi-
gation in structure and function of BLM in BS patients is 
insufficient, which leads to the mechanism of pathopoiesia 
in Bloom’s Syndrome remains elusive. A full description of 
the detailed mechanism of pathopoiesia in the disease 
requires a deeper understanding about the BLM protein. 
The biological study of the helicase will provide valuable 
information towards elucidating the mechanism of 
pathopoiesia. To this end, the purification of BLM protein 
and unraveling of its biological activity were the foun-
dation of further study on the mechanism of pathopoiesia. 
At present, the expression methodology of the BLM 
protein includes prokaryocyte expression and eukaryotic 
expression and the former is normally in E. coli cells 
(Janscak et al., 1996), while the latter is in yeast cells 
(Hickson et al., 2001). In order to  uncover  the  character  




of the BLM protein, the protein with the biological activity 
was purified using nickel chelate affinity chromatography 
and size exclusion chromatography in vitro (Guo et al., 
2005). Several modern methods have been developed to 
measure the biological activity of the protein. The 
electrophoretic mobility shift assay, smFRET (single-
molecule fluorescence resonance energy trans-fer), 
fluorescence polarization assay and radiometric assay 
were used to analyze DNA-binding activity and helicase 
activity of the protein (Xu et al., 2003; Yodh et al., 2009; 
Dou and Xi, 2010; Yang et al., 2010). The analytical 
methods of ATPase activity include measuring the 
radioactive γ
-32
 Pi liberated during hydrolysis ATP and the 
release of inorganic phosphate by a colorimetric assay 
(Janscak et al., 2003; Guo et al., 2007). In the current 
study, we have established the effective method that 
expressed BLM
642-1290 
recombinant protein in E.coli BL21 
and obtained higher purity of recombinant protein. Then, 
DNA-binding activity, DNA unwinding activity and 
ATPase activity of the protein had also been assayed, 
employing different methods by which higher biological 
activity of protein might be obtained. The results would be 
significant to provide a better understanding on BLM 
protein and facilitate the elucidation of mechanism of 
pathopoiesia in Bloom’s Syndrome. 
 
 




All chemicals used in this study were analytical grade. Bovine 
serum albumin (BSA), isopropyl-1-thio-α-D-galactopyranoside 
(IPTG), Triton X-100, imidazole, Phenylmethanesulfonyl fluoride 
(PMSF) and Tween 20 were obtained from Solarbio (China). 
Ampicillin and chloramphenicol were provided by Sigma (USA). 
Tryptone and Yeast extract were provided by Oxoid (England). 
Supports of chromatography used for BLM
642-1290
 recombinant 
protein purification: Sephadex G-200 and fast flow affinity chroma-





 expression vector 
 
The recombinant plasmid pET15b-BLM
642–1290
 was donated by 
Professor XuGuang Xi in Curie institute of the 11th university in 
Paris, France. A plasmid for expression of core region of Bloom’s 
Syndrome protein was generated by inserting the core region of 
BLM gene between the NdeI and XhoI sites of pET15b expression 
plasmid (Novagen, Germany). The expression product of the core 
region of BLM gene was consisted of the DEAH, RecQ-Ct and 
HRDC domains (amino acid residues 642-1290). In this study, BLM 
was fused in frame with an N-terminal peptide containing six 
tandem histidine residues. The expression of his-tagged fusion was 
driven by a T7 RNA polymerase promoter. The recombinant 
plasmid was transformed into E. coli B21 in accordance with the 
previous report (Guo et al., 2005). 
 
 
DNA substrates preparation 
 
The PAGE-purified oligonucleotides (Table 1) were purchased from 
Shanghai   biological   engineering   technology   service  Co., LTD  




Table 1. Oligonucleotide sequences used in this study. 
 





















5’ TGACCATCagtttttttttt 3’ 
 




(China). Briefly, two kinds of single-stranded DNA (ssDNA) were 
equally mixed and were denatured in buffer (20 mM Tris-HCl, pH 
7.2, and 100 mM NaCl) by heating in water bath for 5 min at 85°C. 
Then the denatured DNA was slowly annealed at room 
temperature, the annealed products were used as fluorescence-
taged DNA substrates to assay the biological activity of BLM
642-1290
 
recombinant protein according to Xu’s report (Xu et al., 2003). 
 
 
Induced expression of BLM
642-1290
 in Escherichia coli BL21 
 
The 50 µg/ml ampicillin and 30 µg/ml chloramphenicol were added 
to the Luria–Bertani (LB) liquid medium (pH 7.0) containing 10 g/L 
Tryptone, 5 g/L Yeast extract, and 10 g/L NaCl. 1 mL E. coli BL21 
bearing pET15b-BLM
642-1290
 plasmid was added to 1 L LB liquid 
medium. The mixed solution was cultured at 37°C and 200 rpm until 
the A600 reached 0.5 ~ 0.6. The cultured bacterium fluid was 
incubated with shaking at 17°C for 20 h by the addition of IPTG to 
0.45 mM, protein production was induced by IPTG. The bacterias 
were harvested by centrifugation at 4,000 rpm for 15 min, and then 
stored at -80°C. 
 
 




The bacterias were thawed and resuspended in buffer A containing 
20 mM Tris-HCl (pH 7.9), 500 mM NaCl, 10% (v/v) glycerol, 0.1% 
(v/v) Triton X-100, 5 mM imidazole, and 1 mM PMSF. The 
suspended liquid was cracked by ultrasonic breakage (Sonics, 
USA) to reduce viscosity. The insoluble part of the lysate was 
removed by centrifugation at 13,000 rpm for 40 min. The 
supernatant was applied to a 24 ml fast flow affinity 
chromatography column of Chelating Ni
2+ 
Sepharose pre-
equilibrated with buffer A. Then the column was washed with the 
following buffer: 10 column volume (CV) of buffer A, 10CV of buffer 
B containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl, 10% (v/v) 
glycerol, 0.1% (v/v) Triton X-100, 60 mM imidazole, and 1 mM 
PMSF. Finally, the target protein retained on the column was eluted 
by 10 CV of buffer C containing 20 mM Tris-HCl (pH 7.9), 500 mM 
NaCl, 10% (v/v) glycerol and 500 mM imidazole. The whole process 
was monitored by the FPLC system AKTA purifier100 (GE 
Healthcare, USA). High concentration fractions were loaded onto 
FPLC size exclusion chromatography Superdex 200. The column 
was eluted by buffer D containing 20 mM Tris-HCl (pH 7.9), 150 
mM NaCl and 10% (v/v) glycerol. The fractions with target protein 
were pooled, and the mixed liquor was concentrated by one amicon 
membrane to desirable concentration. Then, the target protein was 
stored at -80ºC. The final protein concentration was determined by 
Bradford dye method (Bradford, 1976) with BSA as the standard. 
Purity of the protein was determined by 10% (v/v) SDS-PAGE. 
Western blotting assays 
 
A total of 20 ml of per fraction liquid was analyzed by 10% (v/v) 
SDS-PAGE for western blotting analysis in every lane. Firstly, the 
gels were electroblotted onto NC membrane (Solarbio, China) 
which was blocked in phosphate-buffered saline containing 0.05% 
(v/v) Tween 20 and 5% (w/w) skim milk. Secondly, the membrane 
was incubated with 6 × his-tag rat monoclonal antibodies (dilution 
1:1,000) for 120 min (Beyotime, China), then, washed in phosphate 
buffer containing 0.1% (v/v) Tween 20. Thirdly, the membrane was 
incubated in blocking buffer containing anti-mouse immunoglobulin 
peroxidase (dilution 1:1,000) for 120 min (GE Healthcare, USA). 
Finally, the membrane was washed again by phosphate buffer 
(0.1% v/v) Tween 20) and detected for the target protein by ECL 
chemiluminescence kit (GE Healthcare, USA). 
 
 
DNA-binding activity assays  
 
The DNA-binding activity was analyzed using a Beacon fluores-
cence polarization spectrophotometer (PanVera, USA) as the 
previous report (Xu et al., 2003). The 100 nM BLM
642-1290
 recom-
binant protein was added to 150 µl binding reaction buffer 
containing 2 nM of different lengths of fluorescein-labeled double-
stranded DNA (dsDNA) and ssDNA. Each sample was incubated 
for 5 min at 25°C before being measured by fluorescence 
polarization. The change of anisotropy was recorded every 8 s until 
it was stabilized. The dissociation constants (apparent Kd values) of 
the protein for DNA-binding were calculated by equations (1) and 








1                                                      (1) 
 
where, DT and PT are the total molar concentrations of DNA and 









                                                        (2) 
 
A is the fluorescence anisotropy at a given concentration of protein, 
Amax is the anisotropy at saturation, and Amin is the initial anisotropy. 
 
 
Helicase activity assays 
 
The helicase activity was measured as Xu’s report (2003). An app-







Figure 1. Purification of BLM
642-1290 
recombinant protein was 
resolved in 10% (w/w) SDS-PAGE and stained with coomassie 
blue. lane1, bacteria fluid; lane2, supernatant fluid; lane3, pure 
enzyme solution; lane4, pooled fractions from chitin column; 






Figure 2. Western blotting assay of BLM
642-1290 
recombinant 
protein. Lane 1, the bacterias liquid; lane 2, the supernatant 
pooled; lane 3, pooled fractions from chitin column; lane 4, the 




dsDNA was added to the unwinding buffer (150 ml total) containing 
25 mM Tris-HCl (pH 7.4), 25 mM NaCl, 3 mM MgCl2, and 0.1 mM 
DTT (dithiothreitol) in a temperature-controlled cuvette at 25°C. The 
anisotropy was continuously measured until it was stabilized. After 
that, the BLM
642-1290
 recombinant protein was added to the cuvette. 
Then, the change of anisotropy was assayed immediately. When 
the anisotropy became stable again, 1 mM adenosine triphosphate 
(ATP) was added quickly to the reaction buffer. The change of 
anisotropy was recorded every 8 s until stabilized. 
 
 
ATPase activity assays 
 
The DNA-dependent ATPase activity was measured using 
ultraviolet spectrophotometry based on  PiColorLock  Gold  reagent  




(Innova Biosciences, England). The theory is based on a colorim-
etric estimation of inorganic phosphate (Pi) produced by ATP 
hydrolysis (Chan et al., 1986). The reactions were carried out at 
25°C in buffer containing 0.5 M Tris-HCl (pH 7.4), 0.1 M MgCl2, 2 
nM ssDNA (20, 45, and 63 mer) cofactors and initiated by adding 
10 mM ATP. 200 µl reactions served as the samples were removed 
from the total reactions at 2.5, 5, 7.5, 10, 15, 20, 25, and 30 min. 
After that, 50 µl Gold mix was added in order to terminate ATP 
hydrolysis. Two minutes later, every sample was got steady by 
adding 20 µl stabiliser, then every sample was read at wavelength 
650 nm in ultraviolet spectrophotometer after 30 min. The Aactivity 
(units/ml) was defined as one unit which represented the amount of 
enzyme that catalysed the hydrolysis of 1 µmol substrate per 
minute. The activity of undiluted enzyme sample was given by the 









                                                                       (3) 
 
where, A is concentration of Pi (µmol) determined from the standard 
curve; B is assay time in minutes; C is reciprocal of the enzyme 
dilution factor. 
Steady-state kinetic parameters Km and kcat for ATP were 
measured at a concentration of 400 nM protein. The concentrations 
of ATP varied from 0.1 mM to 1 mM in these measurements. The 










Bacterias-induced expression, supernatant fluid, pooled 
fractions from chitin column, and pure enzyme solution 
were analyzed with 10% SDS-PAGE (Figure 1), respec-
tively. The results showed that the molecular weight 
(MW) of the BLM
642-1290 
recombinant protein was predict-
ted to be 72 KDa in accordance with theoretical value 
and its purity exceeded 95%. The concentration of 
BLM
642-1290 
recombinant protein obtained was 3.48 g/L, 
and around 2.0 - 2.5 mg of pure protein might be obtained 
from each gram of cell paste. 
 
 




Bacterias fluid induced by IPTG, supernatant fluid, pooled 
fractions from chitin column, and pure enzyme solution 
were analyzed by Western blotting (Figure 2). The results 
displayed that four samples had a single band and Mr 
was consonant with each other, which proved that the 
purified protein was the target protein and immune 




DNA-binding activity assays 
 
The   DNA-binding   activity   of   BLM
642-1290
  recombinant  




    
 
 
Figure 3. The binding curve of the BLM
642-1290
 recombinant protein with different lengths DNA. 
Fluorescence anisotropy values were determined as a function of BLM concentration for different lengths 
of ssDNA (A) and dsDNA (B) substrates. Experiments were performed in DNA-binding activity assay 
buffer (20 mM Tris-HCl, pH 7.5) at 25°C. A total of 2 nM fluorescein-labelled DNA was titrated with 
increasing amounts of BLM
642-1290 
recombinant protein. Steady-state fluorescence anisotropy versus the 
fractional saturation of BLM
642-1290 
recombinant protein (see the staircase chart). The degree of saturation 
was estimated directly from the plateau region of the titration curve. At saturation, the moles of BLM
642-
1290 
recombinant protein binding to DNA are equal to the 2nM different lengths fluorescein-labeled DNA, 




protein was analyzed by fluorescence polarization tec-
hnology (Figure 3). It showed that the protein could bind 
with different lengths of ssDNA (Figure 3A) and dsDNA 
(Figure 3B),  however,  the  amounts  of  the  protein  that  






























Figure 4. The detection of the DNA unwinding activity of the BLM
642-1290
 recombinant protein. DNA unwinding activity 
by fluorescence polarization assay. Note: A was the fluorescence anisotropy at time t and A0 was the fluorescence 
anisotropy in the presence of the DNA. As described in the ‘MATERALS and METHODS’ section, 2 nM different 
lengths dsDNA substrate was pre-incubated with 50 nM BLM
642-1290
 recombinant protein for 5 min at 25℃. The 




saturate 2 nM DNA were very different. The fractional 
saturation of the protein was derived from the anisotropy 
determined at each concentration during titration 
(staircase chart), indicating that the fractional saturation 
was markedly different between the two kinds of DNA 
substrates. No significant difference in the fractional 
saturation of the protein bounded with three lengths of 
ssDNA was investigated, conversely an obvious differ-
ence existed when the substrates were dsDNA. The 
differences were assayed via analysis dissociation 
constants (apparent Kd values) for two kinds of DNA 
substrates under equilibrium conditions. The dissociation 
constants (Kd) of either ssDNA or dsDNA as the 
substrates were 1.2 ± 0.2 or 25.7 ± 2.4 µM, respectively, 
suggesting that the BLM
642-1290
 recombinant protein could 
bind stably with ssDNA or dsDNA. The affinity between 
the protein and ssDNA was 20 times higher than that with 
the dsDNA, which indicated that the ability of the protein-







The helicase activity of BLM
642-1290
 recombinant protein 
was tested using fluorescence polarization technology 
(Figure 4). The substrates were 2 nM of dsDNA with 
three different lengths of 3′overhang including 63:14-mer 
(A1A2), 45:21-mer (B1B2) and 56:36-mer (C1C2). It 
demonstrated that the fluorescence anisotropy of protein-
dsDNA complexes was declined with time in the prese-
nce of ATP, which indicated that BLM
642-1290 
recombinant 
protein could unwind three different lengths of 3′ over-
hanged dsDNA in the presence of ATP. The helicase 
activity was no great difference when three lengths of 
dsDNA as the substrates. Moreover, the anis-otropies 
just declined to stable values because the protein could 
bind with the ssDNA.  
 
 
ATPase activity assays 
 
The ATPase activity of BLM
642-1290
 recombinant protein 
was examined by ultraviolet spectrophotometry based on 
PiColorLock Gold reagent (Figure 5). BLM is a DNA 
stimulated ATPase and an ATP-dependent helicase. The 
amounts of Pi were generally increased with the time 
(Figure 5A), which indicated that the ability of the protein 
catalyzed ATP hydrolysis was time-dependent. Besides, 
the ATPase activity of the protein was closely related to 
the length of ssDNA, indicating that the longer the length of ssDNA cofactors were, the higher the  ATPase  activity 
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Figure 5. The detection of the ATPase activity of the BLM
642-1290
 recombinant protein. A: Time course of 
ATP hydrolysis by 400 nM BLM
642–1290
 recombinant protein in the presence of 63-mer, 45-mer, and 20-mer 




protein in the same 
conditions. In each reaction, DNA was present at a concentration of 2 nM and ATP was 500 µM. 
Experiments were performed at 25°C in ATPase activity assay buffer containing 50 mM Tris-HCl (pH 7.5), 




was. Furthermore, the Aactivity of the BLM
642-1290 
recombi-
nant protein was also generally declined with time via 
analysis of Aactivity (Figure 5B). The Km and kcat for ATPase 
were measured at a protein concentration of 400 nM and 
were summarized in Table 2. No remarkable change in Km of the protein was gained when three lengths ofssDNA




Table 2. Properties of ATPase activity of BLM
642-1290




 (mer) VmaxµM/min KmµM Kcat s
-1





63  146.2 ± 25.6 187.6 ± 2.4 6.08 ± 1.7 32.4 ± 2.0 
45  124.3 ± 20.5 185.4 ± 3.8 5.17 ± 1.5 27.9 ± 1.6 




were used as the cofactors. However, the Vmax and Kcat 
were closely related to the length of ssDNA, increased 
with the length of ssDNA cofactors, which proved the 





In this study, we have characterized recombinant core 
region (amino acid residues 642-1290) of BLM helicase 
including the DEAH, RecQ-Ct and HRDC domains. 
Firstly, the BLM
642-1290
 recombinant protein was expre-
ssed in E. coli induced by 0.45 mM IPTG, purified by the 
ion-change chromatography and FPLC size exclusion 
chromatography, consequently the target protein with the 
purity of more than 95% was obtained. Target protein of 
72 KDa with higher purity was consistent with previous 
report by Janscak et al. (2003). Rather, biological activity 
of recombinant protein including DNA-binding activity and 
helicase activity were confirmed by fluorescence polar-
ization assay. Additionally, ATPase activity was further 
confirmed using the ultraviolet spectrophotometry in vitro. 
Core region of the BLM helicase is an important part of 
the RecQ helicase family members (Bachrati and 
Hickson, 2008). Undoubtedly, biological activity of this 
core region was very important for the whole BLM 
helicase. Results verified the region had biological activity 
for DNA-binding, DNA unwinding and ATPase activity, 
which suggested that amino acid residues 642 - 1290 still 
retained the enzymatic activities as the full-size BLM in 
this study. 
In order to obtain enough BLM protein and understand 
its biological activity in vitro, we have established an 
effective prokaryocyte expression method based on 
Guo’s description (Guo et al., 2007). Our methods 
yielded typically 2 - 2.5 mg of pure protein per 1 g of cell 
paste, which was higher than previous study (Janscak et 
al., 2003). This method shortened the purification period 
and reduced the damage of protein in contrast with Guo’s 
methods, which was contributed to three gradients elution 
of imidazole including 5, 60 and 500 mM in ion-change 
chromatography. The whole process just took five hours, 
contrarily, the Guo’s methods employing five linear 
gradients of imidazole and several pH gradients take at 
least seven hours (Guo et al., 2007; Bugreev et al., 2007; 
Ren et al., 2007). Besides, the whole process was 
monitored by the FPLC which was completely self-driven 
instead of the man-made operation, resulting in the 
reduced the external destruction to the protein.  
The property of molecules fluid and reaction property of 
basic groups of ssDNA were diversified depending on 
dsDNA. In comparison with dsDNA, the ssDNA has more 
hydrogen ions (H
+
) or hydroxyl ions (OH
-
) exposed to the 
reaction buffer than the dsDNA, which might increase the 
affinity between the protein and ssDNA. In addition, 
mutagenesis and structural studies of a number of other 
RecQ family helicase members demonstrated that DEAH 
domain are responsible for coupling of ATP hydrolysis to 
DNA binding, translocation and unwinding (Rigu et al., 
2008; Vindignil and Hickson, 2009). A recent NMR 
structure of the HRDC domain of Sgs1 (the single RecQ 
homologue in Saccharomyces cerevisiae) suggested that 
this domain might function as an auxiliary DNA binding 
domain (Bernstein et al., 2009). The role of the RecQ-Ct 
domain in the helicase remains to be determined (Satoru 
et al., 2009), however the C-terminal region lacked 
catalytic activity which was essential for the maintenance 
of chromosomal stability and nucleolar localization in 
human cells (Popuri et al., 2009). According to the above 
reasons, it can be concluded that the DEAH domain was 
easier to bind with ssDNA than that with dsDNA and 
coupling of ATP hydrolysis in the ssDNA reaction buffer 
under the assistance of the HRDC domain. Because the 
BLM protein is DNA-dependent helicase, that is, the 
catalyze ATP hydrolysis must be in the presence of the 
DNA (Yodh et al., 2009). The longer the length of ssDNA 




 were exposed to the 
reaction buffer, the easier the protein bound to the longer 
ssDNA cofactors, the higher the ATPase activity was. 
It is noteworthy that interaction between BLM helicase 
and DNA plays an important role in regulating functions 
of cellular and virus in the body. The mechanisms of how 
BLM helicase and DNA interact with each other to control 
transcription and replication of somatic cells are gradually 
being elucidated. At present, there are lots of methods to 
research on DNA-helicase interaction such as gel-shift 
assays, foot printing and so on, each of which may 
contribute distinct information about the effect of inter-
action, but they failed to provide a practically easy way to 
quantitatively analyze the interaction (Lawrence et al., 
2008). However, fluorescence polarization used in 
present study was proved to be a more rapid, more 
accurate, and non-radioactive method than other methods 
to measure directly the interaction between DNA and 
protein in solution (Guo et al., 2005; Liu et al., 2007; 
Yang et al., 2010), revealing that this method may be 
used to investigate on DNA-helicase interactions. Further-
more,   we   studied  the  DNA-binding  activity  and  DNA  




helicase activity of BLM
642–1290
 recombinant protein using 
fluorescence polarization, which may be significant to 
provide a better understanding on BLM protein and 
facilitate the elucidation of the mechanism of pathop-
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